142 related articles for article (PubMed ID: 28094108)
1. Analysis of primary treatment and prognosis of spontaneous urticaria.
Tanaka T; Hiragun M; Hide M; Hiragun T
Allergol Int; 2017 Jul; 66(3):458-462. PubMed ID: 28094108
[TBL] [Abstract][Full Text] [Related]
2. [ANALYSIS OF PRIMARY TREATMENT AND PROGNOSIS OF SPONTANEOUS URTICARIA IN A LOCAL CLINIC OF OFFICE DERMATOLOGY].
Tanaka T; Hiragun M; Hide M; Hiragun T
Arerugi; 2015 Sep; 64(9):1261-8. PubMed ID: 26657913
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine.
Hiragun M; Hiragun T; Mihara S; Akita T; Tanaka J; Hide M
Allergy; 2013 Feb; 68(2):229-35. PubMed ID: 23205732
[TBL] [Abstract][Full Text] [Related]
4. Physical urticaria: prevalence, type and natural course in a tropical country.
Silpa-archa N; Kulthanan K; Pinkaew S
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1194-9. PubMed ID: 21175877
[TBL] [Abstract][Full Text] [Related]
5. Natural course and prognostic factors of chronic urticaria in Korean children: A single center experience.
Park H; Lee JY; Song A; Jung M; Kim M; Sohn I; Kim M; Cho J; Ahn K; Kim J
Asian Pac J Allergy Immunol; 2019 Mar; 37(1):19-24. PubMed ID: 29888927
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
Metz M; Ohanyan T; Church MK; Maurer M
J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
[TBL] [Abstract][Full Text] [Related]
7. The predictive factors for remission of chronic spontaneous urticaria in childhood: Outcome from a prospective study.
Eser I; Yologlu N; Baydemir C; Aydogan M
Allergol Immunopathol (Madr); 2016; 44(6):537-541. PubMed ID: 27477033
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
[TBL] [Abstract][Full Text] [Related]
9. Allergists and dermatologists have far more expertise in caring for patients with urticaria than other specialists.
Henderson RL; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2000 Dec; 43(6):1084-91. PubMed ID: 11100028
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Therapeutic Management of Chronic Urticaria by Dermatologists and the Role of Dermatology Departments.
Giménez-Arnau AM; Vilar Alejo J; Moreno Ramirez D;
Actas Dermosifiliogr; 2015 Sep; 106(7):528-32. PubMed ID: 25958009
[No Abstract] [Full Text] [Related]
11. The natural history of chronic urticaria in childhood: a prospective study.
Chansakulporn S; Pongpreuksa S; Sangacharoenkit P; Pacharn P; Visitsunthorn N; Vichyanond P; Jirapongsananuruk O
J Am Acad Dermatol; 2014 Oct; 71(4):663-8. PubMed ID: 25023899
[TBL] [Abstract][Full Text] [Related]
12. Acquired cold urticaria: Clinical features, particular phenotypes, and disease course in a tertiary care center cohort.
Deza G; Brasileiro A; Bertolín-Colilla M; Curto-Barredo L; Pujol RM; Giménez-Arnau AM
J Am Acad Dermatol; 2016 Nov; 75(5):918-924.e2. PubMed ID: 27485164
[TBL] [Abstract][Full Text] [Related]
13. Natural course of new-onset urticaria: Results of a 10-year follow-up, nationwide, population-based study.
Eun SJ; Lee JY; Kim DY; Yoon HS
Allergol Int; 2019 Jan; 68(1):52-58. PubMed ID: 29945815
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
Song CH; Stern S; Giruparajah M; Berlin N; Sussman GL
Ann Allergy Asthma Immunol; 2013 Feb; 110(2):113-7. PubMed ID: 23352531
[TBL] [Abstract][Full Text] [Related]
15. Chronic Spontaneous Urticaria: A Questionnaire Survey.
Gattey N; Bahrani B; Hull PR
J Cutan Med Surg; 2016 May; 20(3):241-3. PubMed ID: 26678077
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and natural history of physical urticaria in children.
Khakoo G; Sofianou-Katsoulis A; Perkin MR; Lack G
Pediatr Allergy Immunol; 2008 Jun; 19(4):363-6. PubMed ID: 18167159
[TBL] [Abstract][Full Text] [Related]
17. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria.
Kaplan A; Ferrer M; Bernstein JA; Antonova E; Trzaskoma B; Raimundo K; Rosén K; Omachi TA; Khalil S; Zazzali JL
J Allergy Clin Immunol; 2016 Feb; 137(2):474-81. PubMed ID: 26483177
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience.
Ensina LF; Valle SO; Juliani AP; Galeane M; Vieira dos Santos R; Arruda LK; Melo JM; de Souza PK; Serpa FS; de Andrade DM; França AT; Campos RA; Camelo-Nunes I; Solé D
Int Arch Allergy Immunol; 2016; 169(2):121-4. PubMed ID: 27055122
[TBL] [Abstract][Full Text] [Related]
19. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.
Metz M; Ohanyan T; Church MK; Maurer M
JAMA Dermatol; 2014 Mar; 150(3):288-90. PubMed ID: 24477320
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab therapy for chronic spontaneous urticaria: the Israeli experience.
Rottem M; Segal R; Kivity S; Shamshines L; Graif Y; Shalit M; Kessel A; Panasoff J; Cohen S; Toubi E; Agmon-Levin N
Isr Med Assoc J; 2014 Aug; 16(8):487-90. PubMed ID: 25269339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
